High-grade B cell lymphoma, unclassifiable, with blastoid features: An unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis

Histopathology

Volumn 61, Issue 5, 2012, Pages 945-954

  Kanagal Shamanna, Rashmi ^a   Medeiros, L Jeffrey ^a   Lu, Gary ^a   Wang, Sa A ^a   Manning, John T ^a   Lin, Pei ^a   Penn, Gerald M ^b   Young, Ken H ^a   You, M James ^a   Vega, Francisco ^a   Bassett, Roland ^a   Miranda, Roberto N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Mary Rutan Hospital   (United States)

Author keywords

BCL2 rearrangement; Blastoid; Double hit; High grade B cell lymphoma unclassifiable; MYC rearrangement

Indexed keywords

MYC PROTEIN; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOGENETICS; DISEASE CLASSIFICATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; KARYOTYPING; LARGE CELL LYMPHOMA; LYMPHOBLASTOID CELL; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; FEMALE; GENE REARRANGEMENT; GENES, BCL-2; GENES, MYC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; KARYOTYPING; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS;

BLASTOIDEA;

EID: 84868008393     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04301.x     Document Type: Article

References (24)

1. Borowitz MJ, Chan JKC. B lymphoblastic leukemia/lymphoma, not otherwise specified. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Eds). WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. Lyon: International Agency for Research on Cancer (IARC), 2008; 168-170.
2. Swerdlow SH, Campo E, Seto M et al. Mantle cell lymphoma. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Eds). WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. Lyon: International Agency for Research on Cancer (IARC), 2008; 229-232.
3. Leoncini L, Delsol G, Gascoyne RD et al. Aggressive B-cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology. Histopathology 2005; 46; 241-255.
4. Inamdar KV, Medeiros LJ, Jorgensen JL, Amin HM, Schlette EJ. Bone marrow involvement by marginal zone B-cell lymphomas of different types. Am. J. Clin. Pathol. 2008; 129; 714-722.
5. Khoury JD, Sen F, Abruzzo LV, Hayes K, Glassman A, Medeiros LJ. Cytogenetic findings in blastoid mantle cell lymphoma. Hum. Pathol. 2003; 34; 1022-1029.
6. Shaffer LG, Campbell LJ, Slovak ML. ISCN (2009): Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature, Basel, Switzerland: S. Karger AG, 2009.
7. Hans CP, Weisenburger DD, Greiner TC et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103; 275-282.
8. Visco C, Li Y, Xu-Monette ZY et al. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP consortium program study. Leukemia 2012; epub 22 March. doi: 10.1038/leu.2012.83.
9. Jaffe ES, Pittaluga S. Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification. Hematology Am. Soc. Hematol. Educ. Program 2011; 2011; 506-514.
10. Aukema SM, Siebert R, Schuuring E et al. Double-hit B-cell lymphomas. Blood 2011; 117; 2319-2331.
11. Li S, Lin P, Fayad LE et al. B-cell lymphomas with MYC/8q24 rearrangements and IGH-BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome. Mod. Pathol. 2012; 25; 145-156.
12. Snuderl M, Kolman OK, Chen YB et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am. J. Surg. Pathol. 2010; 34; 327-340.
13. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403; 503-511.
14. Rosenwald A, Wright G, Chan WC et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 2002; 346; 1937-1947.
15. Wang SA, Wang L, Hochberg EP, Muzikansky A, Harris NL, Hasserjian RP. Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. Am. J. Surg. Pathol. 2005; 29; 1490-1496.
16. Natkunam Y, Warnke RA, Zehnder JL, Jones CD, Milatovich-Cherry A, Cornbleet PJ. Blastic/blastoid transformation of follicular lymphoma: immunohistologic and molecular analyses of five cases. Am. J. Surg. Pathol. 2000; 24; 525-534.
17. Vaidyanathan G, Ngamphaiboon N, Hernandez-Ilizaliturri FJ. Clinical spectrum and prognosis of follicular lymphoma with blastoid transformation: case series and a review of the literature. Ann. Hematol. 2011; 90; 955-962.
18. Mohamed AN, Palutke M, Eisenberg L, Al-Katib A. Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variant. Cancer Genet. Cytogenet. 2001; 126; 45-51.
19. Agarwal AM, Agarwal N, Glenn MJ, Lim MS. Blastic transformation of low-grade follicular lymphoma. J. Clin. Oncol. 2007; 25; 2326-2328.
20. Prakash S, Swerdlow SH. Nodal aggressive B-cell lymphomas: a diagnostic approach. J. Clin. Pathol. 2007; 60; 1076-1085.
21. Vasef MA, Brynes RK, Murata-Collins JL, Arber DA, Medeiros LJ. Surface immunoglobulin light chain-positive acute lymphoblastic leukemia of FAB L1 or L2 type: a report of 6 cases in adults. Am. J. Clin. Pathol. 1998; 110; 143-149.
22. Khalidi HS, Brynes RK, Medeiros LJ et al. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in 'lymphoid' blasts and a comparison of morphologic, immunophenotypic, and molecular findings. Mod. Pathol. 1998; 11; 1211-1221.
23. Chiu A, Frizzera G, Mathew S et al. Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma. Mod. Pathol. 2009; 22; 1507-1517.
24. Yamaguchi M, Nakamura N, Suzuki R et al. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients. Haematologica 2008; 93; 1195-1202.